John Christopher Lindon
Directeur/Bestuurslid bij Metabometrix Ltd.
Profiel
John Christopher Lindon is currently a Director at Metabometrix Ltd.
and a Professor at Imperial College London.
Previously, he was a Professor of Biomolecular Medicine at the University of London and Head of Spectroscopy at Wellcome Research Laboratories.
He received his undergraduate degree from the University of Birmingham.
Actieve functies van John Christopher Lindon
| Bedrijven | Functie | Begin |
|---|---|---|
Metabometrix Ltd.
 Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | - |
| Imperial College London | Corporate Officer/Principal | - |
Eerdere bekende functies van John Christopher Lindon
| Bedrijven | Functie | Einde |
|---|---|---|
| Wellcome Research Laboratories | Corporate Officer/Principal | 01-01-1995 |
| University of London | Corporate Officer/Principal | - |
Opleiding van John Christopher Lindon
| University of Birmingham | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Metabometrix Ltd.
Metabometrix Ltd. Miscellaneous Commercial ServicesCommercial Services Metabometrix Ltd. provides metabonomics research services. It uses nuclear magnetic resonance technology to generate and interpret high-density metabolic data using robotic flow-injection technology. The firm markets its metabonomic technologies to pharmaceutical and biotechnology companies. Metabometrix was founded by Jeremy Kirk Nicholson in 2000 and is headquartered in London, the United Kingdom. | Commercial Services |
| Wellcome Research Laboratories |
